DR.REDDY'S LABORATORIES LTD. - 500124 - Board Meeting Intimation for Audited Standalone And Consolidated Financial Results Of The Company For The Quarter And Financial Year Ending On March 31, 2023, And To Recommend Dividend, If Any, For The Financial Year 2022-23.
DR.REDDY''s LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/05/2023 ,inter alia, to consider and approve Audited Standalone and Consolidated Financial Results of the Company for the quarter and financial year ending on March 31, 2023, and to recommend dividend, if any, for the financial year 2022-23.23-03-2023
